Bosh sahifaSRT • ETR
add
Sartorius AG
Yopilish kursi
186,60 €
Kunlik diapazon
180,00 € - 188,20 €
Yillik diapazon
131,40 € - 230,00 €
Bozor kapitalizatsiyasi
15,36 mlrd EUR
Oʻrtacha hajm
4,82 ming
Narx/foyda
122,22
Dividend daromadliligi
0,39%
Asosiy maydon
ETR
Yangiliklarda
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
| (EUR) | sen, 2025info | Y/Y qiyosi |
|---|---|---|
Daromad | 843,20 mln | 6,25% |
Joriy xarajat | 263,60 mln | -4,80% |
Sof foyda | 43,80 mln | 208,45% |
Sof foyda marjasi | 5,19 | 189,94% |
Har bir ulushga tushum | 1,08 | 24,14% |
EBITDA | 233,20 mln | 37,50% |
Amaldagi soliq stavkasi | 26,94% | — |
Balans
Jami aktivlari
Jami passivlari
| (EUR) | sen, 2025info | Y/Y qiyosi |
|---|---|---|
Naqd pul va qisqa investitsiyalar | 389,90 mln | -32,68% |
Jami aktivlari | 9,61 mlrd | -1,84% |
Jami passivlari | 5,80 mlrd | -3,60% |
Umumiy kapital | 3,81 mlrd | — |
Tarqatilgan aksiyalar | — | — |
Narxi/balansdagi bahosi | — | — |
Aktivlardan daromad | 3,30% | — |
Kapitaldan daromad | 3,92% | — |
Pul aylanmasi
Naqd pulning sof oʻzgarishi
| (EUR) | sen, 2025info | Y/Y qiyosi |
|---|---|---|
Sof foyda | 43,80 mln | 208,45% |
Operatsiyalardan naqd pul | 221,60 mln | -16,72% |
Sarmoyadan naqd pul | -210,90 mln | -125,56% |
Moliyadan naqd pul | -440,80 mln | -136,73% |
Naqd pulning sof oʻzgarishi | -429,00 mln | -3 505,04% |
Boʻsh pul | -12,04 mln | -115,50% |
Haqida
Sartorius AG is an international pharmaceutical and laboratory equipment supplier. In September 2021, Sartorius was admitted to the DAX, Germany's largest stock market index. Sartorius develops and produces biotech drugs and vaccines. The company has two major divisions: Bioprocess Solutions and Lab Products & Services. Wikipedia
Tashkil etilgan
1870
Sayt
Xodimlar soni
13 878
